Delivery Order SPE2DR25D1004-SPE2DR26FSWB0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,441.60 to AmerisourceBergen Drug Corp for IPOL Vial 5ML, an inactivated polio vaccine product. Issued on April 24, 2025, with completion scheduled for April 25, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for IPOL vial 5ML, an inactivated polio vaccine product. The contract is a firm fixed price delivery order with an ultimate completion date of October 29, 2025, and represents a non-set-aside competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $53.6K delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for supply of Ipol Vial 5ML, a polio vaccine product. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 8, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999M and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $54,368.42 to AmerisourceBergen Drug Corp for the supply of IPOL vial 5ML, a poliomyelitis vaccine product. This firm fixed price, competitively awarded delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader...
- This delivery order, valued at $72,979.90 with an ultimate completion date of November 3, 2025, was awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of IPOL Vial 5ML, a polio vaccine product. The contract employs firm fixed pricing and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in...
- The Defense Logistics Agency awarded a $5,450.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of IPOL vial 5ML, an inactivated polio vaccine. This competitively awarded, non-set-aside contract represents a routine pharmaceutical procurement supporting military medical supply requirements. The delivery order is scheduled for completion by June 9, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ipol Vial 5ML, a poliomyelitis vaccine product. This firm fixed price delivery order has a ceiling value of $31,302.96 and an ultimate completion date of August 22, 2025, with no set-aside designation. The contract represents a non-competitive award made under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for a 5mL vial of Ipol (polio vaccine) on July 22, 2025, with an ultimate completion date of July 23, 2025. This delivery order was competitively awarded with firm fixed pricing and no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,652.21 to AmerisourceBergen Drug Corp for IPOL vial 5ML, a poliomyelitis vaccine product. The contract, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, is a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a competitive procurement action under an existing contract...
- The Defense Logistics Agency awarded a $10,413.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IPOL Vial 5ML, a polio vaccine product. This non-set-aside award was issued on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSWB0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,486.01 to AmerisourceBergen Drug Corp for the supply of Ipol Vial 5ML, an inactivated polio vaccine. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 5, 2025. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen's role as a critical vendor within the Defense Logistics Agency's medical supply chain reflects its capability to fulfill federal procurement requirements for vaccines, specialty medications, and other essential healthcare commodities in support of the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 12/3/25 |